✦ LIBER ✦

547 KOS-862 (Epothilone D): Phase 1 dose escalating and pharmacokinetic (PK) study in patients (Pts) with advanced malignancies

✍ Scribed by D.R. Spriggs; J. Dupont; S. Pezzulli; J. Larkin; G. Cropp; Y. Zhou; M. Sherrill; R. Johnson Jr.; A.L. Hannah

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-escalating trial of KOS-862

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase I clinical, pharmacokinetic, and p

✍ Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robe 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 270 KB

Erratum to: Phase I clinical, pharmacoki

✍ Jason Konner, Rachel N. Grisham, Jae Park, Owen A. O’Connor, Gillian Cropp, Robe 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 56 KB

A phase 1 study of KOS-862 (Epothilone D

✍ J. Paul Monk, Miguel Villalona-Calero, Joe Larkin, Greg Otterson, David S. Sprig 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 220 KB

711 POSTER Sunitinib (SU) plus docetaxel

✍ A. Traynor; A. Sandler; J.H. Schiller; J. Ilagan; K. Harper; W. VerMeulen; G. Li 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB